EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:750145 - secukinumab
| ChEBI ID | CHEBI:750145 |
| ChEBI Name | secukinumab |
| Stars | |
| Last Modified | 29 June 2026 |
| Submitter | chembl-etl |
| Roles Classification |
|---|
| Biological Roles: | antiviral agent A substance that destroys or inhibits replication of viruses. immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. |
| Applications: | antirheumatic drug A drug used to treat rheumatoid arthritis. dermatologic drug A drug used to treat or prevent skin disorders or for the routine care of skin. ophthalmology drug Any compound used for the treatment of eye conditions or eye diseases. anti-inflammatory agent Any compound that has anti-inflammatory effects. hypoglycemic agent A drug which lowers the blood glucose level. antipsoriatic A drug used to treat psoriasis. immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. anti-asthmatic agent Any compound that has anti-asthmatic effects. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| secukinumab (CHEBI:750145) has role anti-asthmatic agent (CHEBI:65023) |
| secukinumab (CHEBI:750145) has role anti-inflammatory agent (CHEBI:67079) |
| secukinumab (CHEBI:750145) has role antipsoriatic (CHEBI:50748) |
| secukinumab (CHEBI:750145) has role antirheumatic drug (CHEBI:35842) |
| secukinumab (CHEBI:750145) has role antiviral agent (CHEBI:22587) |
| secukinumab (CHEBI:750145) has role dermatologic drug (CHEBI:50177) |
| secukinumab (CHEBI:750145) has role hypoglycemic agent (CHEBI:35526) |
| secukinumab (CHEBI:750145) has role immunosuppressive agent (CHEBI:35705) |
| secukinumab (CHEBI:750145) has role ophthalmology drug (CHEBI:66981) |
| secukinumab (CHEBI:750145) is a organic molecular entity (CHEBI:50860) |
| Synonyms | Source |
|---|---|
| AIN-457 | ChEMBL |
| AIN457 | ChEMBL |
| AIN457A | ChEMBL |
| Cosentyx | ChEMBL |
| Secukinumab | ChEMBL |